KRT14 and neoplasm: Malignant tumor cells were identified as mesenchymal cells based on their negative immunolabeling for cytokeratin A1/AE3 and their positive vimentin immunoreaction, together with the lack of expression of the MEC markers cytokeratin 14 and p63.